Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A0JDBC7
Tue, 06.02.2024
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
Preliminary group result 2023 (unaudited) / forecast 2024
Total revenue EUR 37.4m + 26 %
Patient days 46,641 + 26 %
Gross earnings (EBITDA) 7.4 Mio. EUR - 15 %
Operating result (EBIT) 4.7 Mio. EUR - 22 %
Consolidated net income for the period 3,395 kEUR - 30 %
Earnings after minoriti [ … ]
Mon, 18.12.2023
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
LIMES Schlosskliniken expands Management Board
Cologne, December 18, 2023. At its meeting today, the Supervisory Board of LIMES Schlosskliniken AG appointed Dr. Brolund-Spaether (47) to the Management Board with effect from 01.01.2024.
Dr. Brolund-Spaether has been working for LIMES Schlosskliniken as Chief [ … ]
Wed, 12.07.2023
Limes Schlosskliniken AG
DGAP-Adhoc: LIMES Schlosskliniken AG:
LIMES Schlosskliniken AG acquires a stake in the Liechtenstein CLINICUM ALPINUM AG
LIMES Schlosskliniken AG, Cologne/Gaflei, FL, July 12, 2023. LIMES Schlosskliniken AG has acquired 51% of the Liechtenstein private clinic CLINICUM ALPINUM AG via a capital increase. 49% of the shares continue to be held by the [ … ]
Wed, 12.07.2023
Limes Schlosskliniken AG
DGAP-Adhoc: LIMES Schlosskliniken AG:
LIMES Schlosskliniken AG acquires a stake in the Liechtenstein CLINICUM ALPINUM AG
LIMES Schlosskliniken AG, Cologne/Gaflei, FL, July 12, 2023. LIMES Schlosskliniken AG has acquired 51% of the Liechtenstein private clinic CLINICUM ALPINUM AG via a capital increase. 49% of the shares continue to be held by the [ … ]
Thu, 22.06.2023
Limes Schlosskliniken AG
DGAP-Corporate News: LIMES Schlosskliniken AG:
LIMES Schlosskliniken AG increases stake in Swiss clinic PRC Group AG
LIMES Schlosskliniken AG, Cologne, 22.06.2023. LIMES Schlosskliniken AG has acquired a further
5 percent of the Swiss PRC Group AG. The remaining 44 percent are held by the management of the Paracelsus Group. This brings the total [ … ]
Thu, 22.06.2023
Limes Schlosskliniken AG
DGAP-Corporate News: LIMES Schlosskliniken AG:
LIMES Schlosskliniken AG increases stake in Swiss clinic PRC Group AG
LIMES Schlosskliniken AG, Cologne, 22.06.2023. LIMES Schlosskliniken AG has acquired a further
5 percent of the Swiss PRC Group AG. The remaining 44 percent are held by the management of the Paracelsus Group. This brings the total [ … ]
Wed, 03.05.2023
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
LIMES Schlosskliniken acquires Schlossklinik Abtsee in Berchtesgadener Land / Group development QI
Cologne, May 03, 2023 - LIMES Schlosskliniken AG today acquired the property of Schlossklinik Abtsee from Bergman Deutsche Klinik Laufen GmbH. The previous clinic operation as a vein center with plastic surgery [ … ]
Wed, 03.05.2023
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
LIMES Schlosskliniken acquires Schlossklinik Abtsee in Berchtesgadener Land / Group development QI
Cologne, May 03, 2023 - LIMES Schlosskliniken AG today acquired the property of Schlossklinik Abtsee from Bergman Deutsche Klinik Laufen GmbH. The previous clinic operation as a vein center with plastic surgery [ … ]
Thu, 13.04.2023
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
Audited consolidated financial statements 2022 / Approval and adoption of the consolidated financial statements per 31.12.2022 of LIMES Schlosskliniken / Outlook 2023
Total revenue 30.1 Mio. EUR, (p. y. 25.2 Mio. EUR) + 19,1 %
Gross earnings (EBITDA) 8,653 kEUR, (p. y. 6,015 kEUR) + 43,9 %
Operating [ … ]
Thu, 13.04.2023
Limes Schlosskliniken AG
DGAP-Adhoc: Limes Schlosskliniken AG:
Audited consolidated financial statements 2022 / Approval and adoption of the consolidated financial statements per 31.12.2022 of LIMES Schlosskliniken / Outlook 2023
Total revenue 30.1 Mio. EUR, (p. y. 25.2 Mio. EUR) + 19,1 %
Gross earnings (EBITDA) 8,653 kEUR, (p. y. 6,015 kEUR) + 43,9 %
Operating [ … ]